Ethicon
Pelvic mesh plaintiffs accuse Ethicon of destroying evidence
Plaintiffs in the multi-district pelvic mesh litigation against Johnson & Johnson‘s (NYSE:JNJ) Ethicon subsidiary want a federal judge to impose "severe sanctions" for the company’s alleged mishandling and destruction of 10s of thousands of documents in the case.
J&J’s Ethicon teams up with Megadyne on electrosurgery products
First bellwether date set for Boston Scientific in pelvic mesh lawsuits
The 1st bellwether trial in the multi-district litigation filed over Boston Scientific‘s (NYSE:BSX) pelvic mesh products is slated for early next year, a federal judge ordered this week.
Pelvic mesh makers look to settle lawsuits
Five medical device companies that make pelvic mesh implants are hoping to negotiate settlements for the more than 30,000 pending lawsuits they’re facing in the U.S., anonymous sources told Bloomberg.
Medtech inventor claims Ethicon lawyer tricked him into divulging trade secrets
Johnson & Johnson (NYSE:JNJ) and its Ethicon Endo-Surgery subsidiary moved to dismiss a trade-secrets-theft case brought by retired Pennsylvania surgeon Dr. Enrico Nicolo, who claimed that Ethicon has, for years, committed acts of patent infringement against him.
Regulators Down Under issue a hazard alert on J&J’s shoulder surgery guides
Australian healthcare regulators this month issued a hazard alert on a single lot of Johnson & Johnson’s (NYSE:JNJ) surgical assist devices after it was discovered that the orientation guides had arrows on the wrong side, possibly leading to incorrect placement.
MassDevice.com +7 | The top 7 med-tech stories for the week of May 13, 2013
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Another recall for Johnson & Johnson Down Under
Another Johnson & Johnson (NYSE:JNJ) product is the subject of a recall, this time from the Australian Therapeutic Goods Administration
J&J’s Ethicon Endo-Surgery wins FDA approval for Sedasys computer-assisted anesthesia device
Johnson & Johnson‘s (NYSE:JNJ) Ethicon Endo-Surgery division landed a hard-won pre-market approval from the FDA for its Sedasys computer-assisted personalized sedation system.
The PMA follows a back-and-forth with the federal watchdog agency over the device that dates back to the initial PMA submission for the Sedasys system in 2008. Ethicon Endo-Surgery got another shot with the FDA after its original PMA bid was denied.